{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:07:51Z","timestamp":1761718071452},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.neurobiolaging.2008.07.010","type":"journal-article","created":{"date-parts":[[2008,8,29]],"date-time":"2008-08-29T12:00:53Z","timestamp":1220011253000},"page":"889-900","source":"Crossref","is-referenced-by-count":28,"title":["Early diagnostic accuracy and pathophysiologic relevance of an autopsy-confirmed Alzheimer's disease peripheral biomarker"],"prefix":"10.1016","volume":"31","author":[{"given":"Tapan Kumar","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel L.","family":"Alkon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib0001","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1254\/jphs.93.272","article-title":"Amyloid beta peptide specifically promotes phosphorylation and nuclear translocation of the extracellular signal-regulated kinase in cultured rat cortical astrocytes","volume":"93","author":"Abe","year":"2003","journal-title":"J. Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2008.07.010_bib0002","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.tips.2006.12.002","article-title":"PKC signaling deficits: a mechanistic hypothesis for the origins of Alzheimer's disease","volume":"28","author":"Alkon","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib0003","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1212\/01.wnl.0000256043.50901.e3","article-title":"Fluctuations of CSF amyloid-beta levels: implications for a diagnostic and therapeutic biomarker","volume":"68","author":"Bateman","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib0004","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological staging of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib0005","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1242\/jcs.02473","article-title":"Insights into the molecular basis of the differing susceptibility of varying cell types to the toxicity of amyloid aggregates","volume":"118","author":"Cecchi","year":"2005","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib0006","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.neurobiolaging.2006.05.014","article-title":"Increased susceptibility to amyloid toxicity in familial Alzheimer's fibroblasts","volume":"28","author":"Cecchi","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib0007","doi-asserted-by":"crossref","first-page":"11993","DOI":"10.1073\/pnas.91.25.11993","article-title":"Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation","volume":"91","author":"Citron","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib0008","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.neurobiolaging.2005.07.003","article-title":"Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment","volume":"27","author":"de Leon","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib0009","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neulet.2007.07.011","article-title":"Potential biomarkers for dementia in Trinidad and Tobago","volume":"424","author":"Davis","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00010","first-page":"1070","article-title":"Risk factors and protective factors for Alzheimer's disease","volume":"7","author":"Desai","year":"1999","journal-title":"Clin. Geriatr."},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00011","doi-asserted-by":"crossref","first-page":"8209","DOI":"10.1073\/pnas.90.17.8209","article-title":"Potassium channel dysfunction in fibroblasts identifies patients with Alzheimer disease","volume":"90","author":"Etcheberrigaray","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00012","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1126\/science.8146663","article-title":"Soluble beta-amyloid induction of Alzheimer's phenotype for human fibroblast K+ channels","volume":"264","author":"Etcheberrigaray","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00013","doi-asserted-by":"crossref","first-page":"11141","DOI":"10.1073\/pnas.0403921101","article-title":"Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice","volume":"101","author":"Etcheberrigaray","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00014","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.20730","article-title":"Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid A\u03b242 in humans","volume":"59","author":"Fagan","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00015","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1073\/pnas.95.10.5562","article-title":"Alzheimer's-specific effects of soluble beta-amyloid on protein kinase C-alpha and -gamma degradation in human fibroblasts","volume":"95","author":"Favit","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00016","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1096\/fasebj.12.1.17","article-title":"Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease","volume":"12","author":"Gasparini","year":"1998","journal-title":"FASEB J."},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00017","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0140-6736(03)12981-9","article-title":"Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease","volume":"361","author":"Goldstein","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00018","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1212\/WNL.43.12.2581","article-title":"Cytosol protein kinase C downregulation in fibroblasts from Alzheimer's disease patients","volume":"43","author":"Govoni","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00019","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1159\/000107700","article-title":"Peripheral inflammatory cytokines as biomarkers in Alzheimer's disease and mild cognitive impairment","volume":"4","author":"Guerreiro","year":"2007","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00020","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study","volume":"3","author":"Hansson","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00021","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/bmj.296.6614.51","article-title":"Development of neurological problems after lumber puncture","volume":"296","author":"Hart","year":"1988","journal-title":"Br. Med. J."},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00022","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000071006","article-title":"The validity and reliability of 6 sets of clinical criteria to classify Alzheimer's disease and vascular dementia in cases confirmed post-mortem: added value of a decision tree approach","volume":"16","author":"Hogervorst","year":"2003","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00023","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00005072-199710000-00002","article-title":"Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease","volume":"56","author":"Hyman","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00024","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1602\/neurorx.1.2.226","article-title":"Biomarker of Alzheimer's disease in plasma","volume":"1","author":"Irizarry","year":"2004","journal-title":"NeuroRx"},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00025","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1073\/pnas.91.2.534","article-title":"Internal Ca2+ mobilization is altered in fibroblasts from patients with Alzheimer disease","volume":"91","author":"Ito","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00026","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/0014-5793(94)01137-0","article-title":"Increased beta-amyloid release and levels of amyloid precursor protein (APP) in fibroblast cell lines from family members with the Swedish Alzheimer's disease APP670\/671 mutation","volume":"354","author":"Johnston","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00027","doi-asserted-by":"crossref","first-page":"13203","DOI":"10.1073\/pnas.0605411103","article-title":"An internally controlled peripheral biomarker for Alzheimer's disease: Erk1 and Erk2 responses to the inflammatory signal bradykinin","volume":"103","author":"Khan","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00028","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1096\/fj.05-4055fje","article-title":"Erk1\/2 is an endogeneous negative regulator of \u03b3-secretase activity","volume":"2","author":"Kim","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00029","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00030","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/archneur.65.6.776","article-title":"Plasma amyloid beta-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease","volume":"65","author":"Locascio","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00031","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1523\/JNEUROSCI.11-09-02759.1991","article-title":"Protein kinase C alteration is an early biochemical marker in Alzheimer's disease","volume":"11","author":"Masliah","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00032","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1212\/01.WNL.0000091890.32140.8F","article-title":"Plasma A[\u03b2]40 and A[\u03b2]42 and Alzheimer's disease: relation to age, mortality, and risk","volume":"61","author":"Mayeux","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00033","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease","volume":"41","author":"Mirra","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00034","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1471-4159.2005.03539.x","article-title":"The beta-amyloid peptide of Alzheimer's disease decreases adhesion of vascular smooth muscle cells to the basement membrane","volume":"96","author":"Mok","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00035","doi-asserted-by":"crossref","first-page":"14854","DOI":"10.1073\/pnas.0504178102","article-title":"A unique gene expression signature discriminates familial Alzheimer's disease mutation carriers from their wild-type siblings","volume":"102","author":"Nagasaka","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00036","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev.publhealth.24.100901.141015","article-title":"Will a healthy lifestyle help prevent Alzheimer's disease?","volume":"24","author":"Pope","year":"2003","journal-title":"Annu. Rev. Public Health"},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00037","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm1653","article-title":"Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins","volume":"13","author":"Ray","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00038","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nm0896-864","article-title":"Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease","volume":"2","author":"Scheuner","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00039","series-title":"The Metabolic Basis of Inherited Disease","author":"Stanbury","year":"1983"},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00040","series-title":"The Metabolic Basis of Inherited Disease","first-page":"731","article-title":"Phytanic acid storage disease (Refsum's disease)","author":"Steinberg","year":"1983"},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00041","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1001\/jama.289.16.2094","article-title":"Decreased \u03b2-amyloid-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer's disease","volume":"289","author":"Sunderland","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00042","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S1474-4422(06)70501-4","article-title":"Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study","volume":"8","author":"van Oijen","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00043","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0002-9440(10)63342-1","article-title":"Calpain mediates calcium-induced activation of the erk1 2 MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer's disease","volume":"165","author":"Veeranna","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00044","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0304-3940(02)01483-0","article-title":"Cerebrospinal fluid biomarkers for disease stage and intensity in cognitively impaired patients","volume":"339","author":"Wahlund","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2990.1986.tb00677.x","article-title":"A comparative study of modified Bielschowsky Bodian and thioflavin S stains on Alzheimer's neurofibrillary tangles","volume":"12","author":"Yamamoto","year":"1986","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00046","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/jcp.20250","article-title":"Bradykinin-induced p42\/p44 MAPK phosphorylation and cell proliferation via Src, EGF receptors, and PI3-K\/Akt in vascular smooth muscle cells","volume":"203","author":"Yang","year":"2005","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00047","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2003.08.011","article-title":"Cerebrospinal fluid markers for prediction of Alzheimer's disease","volume":"352","author":"Zetterberg","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00048","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1006\/nbdi.2002.0520","article-title":"MAP kinase signaling cascade dysfunction specific to Alzheimer's disease in fibroblasts","volume":"11","author":"Zhao","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00049","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0969-9961(03)00124-4","article-title":"Impairment of phosphatase 2A contributes to the prolonged MAP kinase phosphorylation in Alzheimer's disease fibroblasts","volume":"14","author":"Zhao","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2008.07.010_bib00050","first-page":"1155","article-title":"Punch biopsy of the skin","volume":"65","author":"Zuber","year":"2002","journal-title":"Am. Fam. Physician"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458008002546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458008002546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T17:45:29Z","timestamp":1557769529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458008002546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0197458008002546"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2008.07.010","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}